AI-accelerated clinical trials getting new therapies to patients faster at lower costs
Inato helps biopharmaceutical companies increase the pool of available patients in clinical trials by discovering untapped research potential. Its AI-platform automates data collecting, structuring and analysis in clinical trails, cross-checks data sources and provides insights that enable pharmaceutical companies to drastically reduce drug development costs. The marketplace is built with doctors and for doctors to navigate the hurdles of today's increasingly complex research environment. By accelerating clinical trials, Inato helps new therapies arrive to patients faster and at lower prices.